Checkpoint Inhibitors and Hepatotoxicity
Uncontrolled immune response to a pathogen or any protein can lead to tissue damage and autoimmune diseases, that represent aberrant immune responses of the individual to its own cells and/or proteins. The immune checkpoint system is the regulatory mechanism that controls immune responses. Tumor cel...
Main Authors: | Stephen D. H. Malnick, Ali Abdullah, Manuela G. Neuman |
---|---|
פורמט: | Article |
שפה: | English |
יצא לאור: |
MDPI AG
2021-01-01
|
סדרה: | Biomedicines |
נושאים: | |
גישה מקוונת: | https://www.mdpi.com/2227-9059/9/2/101 |
פריטים דומים
-
The Current status of steroid-refractory immune-checkpoint-inhibitor-related hepatotoxicity
מאת: Hui Xing, et al.
יצא לאור: (2023-02-01) -
Kava hepatotoxicity. A clinical review
מאת: Rolf Teschke
יצא לאור: (2010-07-01) -
Incidence, risk factors and outcomes of checkpoint inhibitor-induced liver injury: A 10-year real-world retrospective cohort study
מאת: Edmond Atallah, et al.
יצא לאור: (2023-10-01) -
Hepatotoxicity of Antibacterial Agents in Clinical Practice
מאת: Bueverov A.O., et al.
יצא לאור: (2015-08-01) -
Liraglutide-Induced Hepatotoxicity
מאת: Yaakov Maor, et al.
יצא לאור: (2021-01-01)